These findings were further confirmed by Papkovskaia et al. (2012), who described decreased MMP and ATP levels as well as increased proton leakage and ROS levels with the associated increase in uncoupling protein 2 (UCP2) in fibroblasts from G2019S-LRRK2 PD patients. Here, UCP2 is linked to Parkinson disease.